Circadian-Related Heteromerization of Adrenergic and Dopamine D4 Receptors Modulates Melatonin Synthesis and Release in the Pineal Gland by González, Sergio et al.
Circadian-Related Heteromerization of Adrenergic and
Dopamine D4 Receptors Modulates Melatonin Synthesis
and Release in the Pineal Gland
Sergio Gonza ´lez
1,2, David Moreno-Delgado
1,2, Estefanı ´a Moreno
1,2, Kamil Pe ´rez-Capote
1,2,
Rafael Franco
1,2¤, Josefa Mallol
1,2, Antoni Corte ´s
1,2, Vicent Casado ´
1,2, Carme Lluı ´s
1,2, Jordi Ortiz
3,
Sergi Ferre ´
4., Enric Canela
1,2., Peter J. McCormick
1,2*
.
1Centro de Investigacio ´n Biome ´dica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), University of Barcelona, Barcelona, Spain, 2Department of
Biochemistry and Molecular Biology, Faculty of Biology, University of Barcelona, Barcelona, Spain, 3Neuroscience Institute and Department of Biochemistry and Molecular
Biology, Faculty of Medicine, Universitat Auto `noma de Barcelona, Bellaterra, Spain, 4National Institute on Drug Abuse, Intramural Research Program, National Institutes of
Health, Department of Health and Human Services, Baltimore, Maryland, United States of America
Abstract
The role of the pineal gland is to translate the rhythmic cycles of night and day encoded by the retina into hormonal signals
that are transmitted to the rest of the neuronal system in the form of serotonin and melatonin synthesis and release. Here
we describe that the production of both melatonin and serotonin by the pineal gland is regulated by a circadian-related
heteromerization of adrenergic and dopamine D4 receptors. Through a1B-D4 and b1-D4 receptor heteromers dopamine
inhibits adrenergic receptor signaling and blocks the synthesis of melatonin induced by adrenergic receptor ligands. This
inhibition was not observed at hours of the day when D4 was not expressed. These data provide a new perspective on
dopamine function and constitute the first example of a circadian-controlled receptor heteromer. The unanticipated
heteromerization between adrenergic and dopamine D4 receptors provides a feedback mechanism for the neuronal
hormone system in the form of dopamine to control circadian inputs.
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Introduction
Dopamine receptors are G protein-coupled receptors (GPCRs)
that consist of two major families, the D1-like and D2-like
receptors. D1-like receptors include D1 and D5 subtypes that are
known to stimulate adenylate cyclase activity via a Gs mechanism
and D2-like receptors include D2,D 3, and D4 subtypes that inhibit
adenylate cyclase activity via a Gi mechanism [1]. Of these
subtypes, D1 and D2 and their heteromers constitute the most
abundant in the brain [2–4]. The function of the other dopamine
receptor subtypes has been more difficult to determine. The
dopamine D4 receptor was discovered 20 years ago and initially
drew a lot of attention in view of its significantly higher affinity for
the atypical antipsychotic clozapine compared to the previously
discovered D2 and D3 receptors [5,6]. In the retina, D4 receptors
modulate phototransduction through a mechanism that requires
cAMP [7]. It has been described that Drd4 is the dominant
dopamine receptor gene expressed in the rat pineal gland and that
it is expressed in pinealocytes and retina at levels that are greater
than in other tissues [8]. Rat pineal Drd4 mRNA expression was
found to be circadian in nature and under photoneural control
[8,9]. In the pineal gland, mRNA expression for D4 receptors has
been shown to be tightly regulated and stimulated by norepi-
nephrine through a mechanism involving thyroid hormone [8].
Nevertheless, the amount of D4 receptor protein expression or
function in the pineal gland is currently not known. In this study,
the primary issue under consideration is whether or not dopamine
D4 receptor is active within the pineal gland and what is the
physiological role of agonist binding to D4 receptors with respect
to pineal gland function.
The role of the pineal gland is to translate light inputs from the
retina into chemical signals for the rest of the body. This is
achieved via production and secretion of melatonin by the pineal
gland. Melatonin production occurs on a night/day cycle and is
heavily dependent on the concentration of serotonin (5-HT) [10–
14]. The b1 and a1B adrenergic receptors are the main receptors
that control melatonin production by different mechanisms. One
of them is to control the availability of 5-HT, the melatonin
precursor, by increasing both the activity of tryptophan hydrox-
ylase (TPH) and the release of 5-HT. Another is via a strict
PLoS Biology | www.plosbiology.org 1 June 2012 | Volume 10 | Issue 6 | e1001347regulation of the enzyme that converts 5-HT to melatonin, the
arylalkylamine N-acetyltransferase (AANAT) [15–18]. Despite
tight regulation by the adrenergic receptors it is unclear what
limits the nighttime and daytime rates of melatonin and 5-HT
production. We hypothesized that one important role of dopamine
D4 receptors in the pineal gland can be the modulation of b1 and
a1B adrenergic receptor function. One possibility for such a
modulation could be through a concept becoming widely accepted
for GPCRs, the modulation of function through receptor
heteromer formation [19–29]. A receptor heteromer is a
macromolecular complex composed of at least two functional
receptor units with biochemical properties that are demonstrably
different from those of its individual receptors [30]. Here, using a
combination of approaches including biophysical, molecular and
cellular biology, and metabolic assays from cultured cells to whole,
intact, pineal gland, we explored the possibility that D4 receptor
might modify adrenergic receptor function through direct
receptor-receptor interaction. We report, to our knowledge, the
first heteromer between dopamine and adrenergic receptors,
provide new data that adrenergic receptor control of 5-HT levels
can be modulated via the D4 receptor and show that D4-
adrenergic receptor regulation can alter melatonin production
from the pineal gland.
Results
D4 Receptors Are Functional in the Pineal Gland
The expression of D4 receptor mRNA in the pineal gland
during the dark period has been described, but the functional role
of the protein is unknown [8,31]. Thus we first assessed whether
the receptor was active in the pineal gland. Pineal glands dissected
from rats 1 h from the start of the light period were stimulated
with increasing concentrations of dopamine or with the D4
receptor agonist RO 10-5824 and the levels of p-ERK 1/2 and p-
Akt/PKB were determined. Dopamine increased both p-ERK 1/
2 and p-Akt/PKB to a similar extent as RO 10-5824 (Figure 1A
and B). Moreover, primary cultures of pinealocytes stimulated with
RO 10-5824, the adrenergic a1 receptor agonist phenylephrine, or
the adrenergic b receptor agonist isoproterenol, showed signaling
via p-ERK 1/2 (Figure 1C, red staining). The subcellular
distribution of the pinealocyte marker S-arrestin (green staining)
in the absence of ligands was diffuse, suggesting cytosolic
localization, and in the presence of ligands was found in punctate
structures, indicating recruitment to membrane structures. In
addition, these punctate structures co-localized with the p-ERK 1/
2, confirming receptor activation, since endosomes containing
receptor-arrestin complexes are known to serve as a signaling
platform for p-ERK 1/2 (Figure 1C) [32]. Thus, in both intact
pineal gland and isolated pinealocytes, D4 receptors are functional.
D4 Receptors Form Heteromers with a1B and b1
Receptors in Transfected Cells
Having shown that D4 receptors are functional in the pineal
gland, we sought to test whether D4 receptors might form
heteromers with the adrenergic receptors a1B and b1. We first
examined this possibility using transfected cells. The best assay for
detecting an interaction between two membrane receptors in
transfected cells is through biophysical means using Biolumines-
cence Resonance Energy Transfer (BRET) assays. BRET is
particularly useful for testing for complexes with GPCRs as the
Fo ¨rster distance (distance at which the energy transfer efficiency is
50%) of the BRET pairs used here is 4.4 nm, which is 44
angstroms [33]. A single GPCR has a diameter of ,50 angstroms;
thus, the sensitivity and distance requirements of BRET are well
suited for working with GPCR complexes. BRET experiments
were performed by fusing one of the receptors to the biolumines-
cent protein Renilla Luciferase (RLuc) and the other to a yellow
fluorescent protein (YFP) (Materials and Methods). Prior to BRET
experiments, preliminary experiments showed that fusion proteins
were able to bind their respective ligands with similar affinities
(unpublished data). Next, we confirmed that the fusion proteins
were able to activate p-ERK 1/2 in the same manner as the native
protein (Figure S1) and that all receptors were properly trafficked
to the cell membrane as observed by confocal microscopy
(Figure 2D). Clear BRET saturation curves were obtained in cells
expressing D4-RLuc receptors and increasing amounts of a1B-YFP
or b1-YFP receptors (Figure 2A) with BRETmax values of 7464
mBU and 120610 mBU, respectively, and BRET50 values of
3762 and 6164, respectively, indicating that the two receptors
are indeed forming a higher order structure that allows energy
transfer. In contrast, a low and linear BRET was detected in cells
expressing a1B-RLuc and increasing amounts of b1-YFP
(Figure 2A, gray line); this was qualitatively similar to the results
obtained with the negative control, cells expressing D4-RLuc
receptors and increasing amounts of D1-YFP (Figure 2A, green
line). Taken together, these results strongly suggest that the D4
receptor forms heteromers with both a1B and b1 receptors, but
heteromers are not formed between a1B and b1 receptors.
Although these results show that a1B and b1 do not form
heteromers in cells not expressing D4 receptors, they do not
discount the possibility that there are heterotrimers between D4,
a1B and b1 receptors in cells expressing all three, as has been
previously reported for other GPCRs [34]. If a1B-b1-D4 hetero-
trimers are formed, the molecular determinants on the D4 receptor
that interact with the a1B receptor must be different from those
required to interact with b1 receptors. On the other hand, if a1B
and b1 receptors interact with the same molecular determinants on
the D4 receptor, a1B-b1-D4 receptor heterotrimers will not form
due to the steric hindrance of two receptors competing for the
same region. To test this we performed two parallel experiments.
In the first one we titrated a1B receptors in cells expressing a
constant amount of D4-RLuc and a1B-YFP (Figure 2B). As more
unlabeled a1B was expressed (red line) energy transfer was
Author Summary
Animals respond to cycles of light and dark with patterns
in sleeping, feeding, body temperature alterations, and
other biological functions. The pineal gland translates
these light signals received from the retina into a language
understandable to the rest of the body through the
rhythmic synthesis and release of melatonin in response to
the light and dark cycle. This process is controlled by
adrenergic receptors. One impressive and mysterious
aspect of the system is the rapid ability of rhythmic
melatonin production and/or degradation to respond to
changes in the cycle. In this study, we demonstrate that
part of this response is due to the formation of receptor-
receptor complexes (heteromers) between the adrenergic
receptors a1B or b1 and the D4 dopamine receptor. Using
both biochemical and biophysical methods in transfected
cells and in ex vivo tissue we show that dopamine, a
neurotransmitter, inhibits adrenergic receptor signaling
through these heteromers. This inhibition causes a
dramatic decrease in melatonin production of the pineal
gland. We postulate that these heteromers provide a rapid
feedback mechanism for the neuronal hormone system to
modulate circadian-controlled outputs.
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nearly identical decrease in energy transfer when we titrated b1
receptor. We obtained similar results in the second experiment,
when we titrated a1B or b1 receptors in cells expressing a constant
amount of D4-RLuc and b1-YFP (Figure 2C). One important
observation is that the BRET approached zero as more competing
receptor was added, arguing against the possibility that the
unlabeled receptor is forming a complex with an existing BRET
complex. In the latter scenario, the BRET is likely to remain
relatively constant over a range of concentrations of the competing
receptor.
The advantage of BRET experiments is that they are performed
on live cells in native membranes. However, we sought to confirm
these interactions using the classical method of co-immunoprecip-
itation. We first confirmed that a1B and b1 receptors could be co-
precipitated with D4 receptor. In cells expressing D4-YFP, a1B and
b1 receptors (Figure 2E), immunoprecipitating with anti-D4
receptor antibodies led to co-precipitation of both a1B and b1
receptors (Figure 2F, lanes 7 and 14). We also performed the
reverse, immunoprecipitating with antibodies to a1B or b1
receptors and looking for co-precipitation of D4 receptor.
However, the D4 receptor antibodies do not function by Western
blot, so we blotted the membrane with an anti-YFP antibody.
Immunoprecipitating with either a1B and b1 receptor antibodies
led to co-precipitation of D4 receptors (Figure 2E, lanes 1 and 8).
As controls we performed the immunoprecipitation with an
unrelated antibody, and no a1B and b1 receptors were precipitated
(Figure 2F, lanes 6 and 13). Next, to confirm the BRET
competition experiments detailed above (Figure 2B and C) we
examined the ability of a1B and b1 receptors to co-precipitate each
other. As can be seen in Figure 2F, lanes 2 and 9, a1B and b1
receptors did not co-precipitate. Taken together, these results
confirm the BRET experiments and prompted us to discard the
possibility of a1B-b1-D4 receptor heterotrimers. Control experi-
Figure 1. Functionality of dopamine D4 receptors in pineal gland and pinealocytes. Pineal glands extracted at 9:00 h were treated for
10 min with increasing amounts of dopamine or with 1 mM of RO 10-5824 (RO). The immunoreactive bands, corresponding to ERK 1/2 (Thr
183-Tyr
185)
phosphorylation (A) and Akt (Ser
473) phosphorylation (B), of two separate experiments performed in duplicate were quantified and values represent
the mean 6 S.D. of the fold increase relative to basal levels found in untreated cells. Significant differences with respect to basal levels were
determined by one-way ANOVA followed by a Dunnett’s multiple comparison post hoc test (*p,0.05, **p,0.01, and ***p,0.001). A representative
Western blot is shown at the top (see Materials and Methods). (C) Pinealocytes were isolated from pineal glands extracted at 9:00 h and were treated
with medium (Control), 1 mM of RO 10-5824 (RO), 1 mM phenylephrine (Phenyl), or 1 mM isoproterenol (Iso) for 10 min before labeling with anti-S-
arrestin (green) and anti-phospho-ERK1/2 (red), as indicated in Materials and Methods. Cell nuclei were stained with DAPI (blue). Scale bar, 5 mm.
doi:10.1371/journal.pbio.1001347.g001
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also performed (Figure S2), confirming the above described results.
Functional Consequences of a1B-D4 and b1-D4 Receptor
Heteromer Formation in Transfected Cells
A common and often essential attribute of receptor heteromers
is the ability to modify downstream signaling versus the single
constituent receptors. This type of receptor-receptor interaction
has been observed for several receptor heteromers [35–38]. To
understand the function of a1B-D4 and b1-D4 receptor heteromers,
we investigated whether there were changes in MAPK (ERK 1/2
phosphorylation) and Akt/PKB (Ser-473 Akt phosphorylation)
signaling when heteromers were co-stimulated with both agonists
or blocked with antagonists. In terms of pineal function,
phosphorylation of ERK 1/2 is the last step in a cascade of
signaling that modulates the enzyme that converts 5-HT to N-
acetyl serotonin, thus we felt it pertinent to study changes in this
signaling pathway. First, the selectivity of receptor agonists, RO
Figure 2. D4 receptors form heteromers with a1B and b1 receptors in transfected cells. (A) BRET saturation curves were performed in HEK-
293T cells co-expressing a constant amount of D4-RLuc construct (2 mg of plasmid transfected) and increasing amounts of b1-YFP construct (0.4–5 mg
plasmid transfected, red), a1B-YFP construct (0.4–5 mg of plasmid transfected, blue), or D1-YFP construct (1–4 mg of plasmid transfected, gray) or with
cells co-expressing a constant amount of a1B-RLuc construct (3 mg of plasmid transfected) and increasing amounts of b1-YFP construct (0.4–5 mgo f
plasmid transfected, green). Both fluorescence and luminescence of each sample were measured prior to every experiment to confirm equal
expression of Rluc construct (,100,000 luminescence units) while monitoring the increase of YFP construct expression (2,000 to 40,000 fluorescence
units). Milli BRET Units (mBU) are BRET ratio (see Materials and Methods)61,000 and are expressed as means 6 S.D. of five different experiments
grouped as a function of the amount of BRET acceptor normalized with respect to the BRET donor (YFP/RLuc). (B and C) BRET was determined in HEK-
293T cells expressing a constant amount of D4-RLuc construct (2 mg of plasmid transfected) and (B) a1B-YFP construct (4 mg of plasmid transfected) or
(C) b1-YFP construct (4 mg of plasmid transfected) and increasing amounts (2–12 mg of plasmid transfected) of (B) a1B receptor (red) or b1 receptor
(blue) or (C) b1 receptor (red) or a1B receptor (blue). Both fluorescence and luminescence of each sample were measured prior to every experiment to
confirm that there were no changes in the expression of D4-RLuc, a1B-YFP, or b1-YFP constructs. BRET data (see above) are expressed as means 6 S.D.
of three different experiments. Significant differences with respect to cells not expressing a1B or b1 receptors were calculated by one-way ANOVA
followed by a Dunnett’s multiple comparison post hoc test (*p,0.05 and **p,0.01). (D) Confocal microscopy images of HEK-293T cells transfected
with 1 mg of plasmid coding for D4-RLuc and 0.5 mg of plasmid coding for a1B-YFP or b1-YFP. Proteins were identified by fluorescence or by
immunocytochemistry. D4-RLuc receptor is shown in red, a1B-YFP and b1-YFP receptors are shown in green, and co-localization is shown in yellow.
Scale bar, 5 mm. (E and F) Co-immunoprecipitation of D4 and a1B or D4 and b1 receptors expressed in HEK-293T cells. Membranes from cells
transfected with the indicated receptors were solubilized and processed for immunoprecipitation as described under Materials and Methods using
goat anti-D4R, rabbit anti-a1 or goat anti-b1 receptor antibodies, or as negative controls (NC), goat anti-adenosine A2B receptor antibody (top in F) or
rabbit anti-adenosine A1 receptor antibody (bottom in F). Solubilized membranes (E) and immunoprecipitates (F) were analyzed by SDS-PAGE and
immunoblotted using rabbit anti-YFP, rabbit anti-a1, or goat anti-b1 antibody. IP, immunoprecipitation; WB, Western blotting (numbers are included
to delineate the different lanes on the SDS-PAGE); MW, molecular mass.
doi:10.1371/journal.pbio.1001347.g002
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expressing D4, a1B,o rb1 receptors (Figure 3A). Using a selective
agonist in time-response assays, we found an increase in ERK 1/2
and Akt/PKB phosphorylation in cells only expressing D4, a1B,o r
b1 receptors (Figure S3). We next explored whether any cross-talk
between the receptors could be detected in cells co-expressing the
receptors. In a1B-D4 and b1-D4 receptor co-expressing cells,
stimulation of D4 receptors for 7 min with the D4 specific ligand
RO 10-5824 inhibited a1B and b1 receptor-mediated ERK 1/2
and Akt/PKB activation induced by increasing amounts of
phenylephrine and isoproterenol (Figure 3B to E). We observed
an almost complete block in the amount of p-ERK 1/2 induced by
adrenergic agonists in the presence of RO 10-5824 (Figure 3B and
D), indicating that D4 activation inhibited the a1B and b1 receptor-
mediated ERK 1/2 phosphorylation. In addition, a complete
block of p-Akt production was observed in the presence of both
adrenergic receptor agonist and D4 receptor agonist (Figure 3C
and E), demonstrating that D4 receptor activation inhibited the
a1B and b1 receptor-mediated Akt/PKB phosphorylation and vice
versa. These results are not due to a change in the time in which
the signaling peaks, since differences were not observed in time-
response curves when co-transfected cells were activated with one
or both agonists (Figure S4). In addition, as a negative control, we
confirmed that RO 10-5824 did not modify ERK 1/2 or Akt/
PKB phosphorylation induced by phenylephrine or isoproterenol
in cells transfected with a1B or b1 receptors alone (Figure S5).
In addition to cross-talk at the level of receptor signaling, some
GPCR heterodimers act at the level of ligand binding [36,39–41].
To explore whether D4 receptor ligands can modify the binding of
a1B or b1 receptor ligands, we performed radioligand competition
assays in transfected cells in the presence or absence of the D4
receptor specific ligand RO 10-5824. As can be seen in Figure 3F,
the addition of RO 10-5824 led to a decrease in the ability of
phenylephrine, the a1B receptor agonist, to displace the radiola-
beled a1B receptor antagonist [
3H]-prazosin. The monophasic
competition curve giving an affinity constant (KD1)o f1 0 61n M
changed to a biphasic curve giving a KD1 of 2767 nM and KD2 of
1,6006400 nM in the presence of RO 10-5824, showing negative
cooperativity (cooperativity index of 21.17). These results point
out that agonist binding to the D4 receptor in the heteromer
decreases the affinity of agonist binding to the a1B receptor.
Interestingly, when similar experiments were performed testing
agonist binding to b1 receptors, there were no differences observed
in the displacement curve or the affinity in the presence or absence
of RO 10-5824 (KD1 of 300650 nM and 460680 nM, respec-
tively) (Figure 3G). Taken together, these results imply differences
between a1B-D4 and b1-D4 receptor heteromers in their allosteric
interactions.
We next looked for a heteromer specific biochemical property.
Antagonists, by definition, do not signal; thus, cross-antagonism,
any change in a1B or b1 mediated signaling caused by an
antagonist of D4 receptors, could only be due to protein-protein
contact between the receptors, and would constitute a specific
biochemical characteristic of the heteromer. Prior to looking for
cross-antagonism, we investigated the selectivity of D4, a1B, and b1
receptor antagonists by measuring MAPK and Akt/PKB signaling
in cells transfected with only D4, a1B,o rb1 receptors and
stimulated or not with agonist and treated with the selective D4,
a1B, and b1 receptor antagonists L-745,870, REC 15/2615, and
CGP 20712, respectively. All antagonists behaved as classical
antagonists, since none demonstrated any signaling properties in
transfected cells (Figure S6). Importantly, all antagonists were
selective, as expected, and were able to attenuate agonist-induced
signaling in only their respective receptors (Figure S6). Next, cells
co-expressing a1B-D4 and b1-D4 receptors were treated with
antagonists prior to activation with agonist. We obtained a striking
cross-antagonism in MAPK and Akt/PKB activation (Figure 4). In
both cases, the D4 receptor antagonist L-745,870 was able to
completely block signaling caused by isoproterenol or phenyleph-
rine. Moreover, signaling induced by the D4 receptor agonist was
blocked by the adrenergic receptor antagonist REC 15/2615 and
CGP 20712. These results demonstrate that the dopamine D4
receptor is able to modify a1B and b1 function via receptor
heteromers and vice versa. In addition, this cross-antagonism
constitutes a specific biochemical property of the a1B-D4 and b1-
D4 receptor heteromers and can be used as a biochemical
fingerprint to detect the heteromers in native tissues.
Functional a1B-D4 and b1-D4 Receptor Heteromers in the
Pineal Gland
We next sought to detect a1B-D4 and b1-D4 receptor heteromers
in the pineal gland. We looked for the heteromer biochemical
property identified above, the cross-antagonism, as an initial
demonstration of the existence of a1B-D4 and b1-D4 receptor
heteromers in the pineal gland. Therefore, whole pineal glands
were isolated 1 h after starting the light period and stimulated with
the respective D4, a1B, and b1 agonists RO 10-5824, phenyleph-
rine, and isoproterenol, and p-ERK 1/2 (Figure 4E) and p-Akt
(Figure 4F) signaling were measured with respect to basal levels. As
can be seen in Figure 4E and F, all three receptors showed robust
signaling that could be attenuated with the respective antagonist
(L-745,870, REC 15/2615, and CGP 20712). We also detected a
cross-antagonism in MAPK and Akt/PKB activation. In both
cases, the D4 receptor antagonist L-745,870 was able to block
completely the signaling caused by isoproterenol or phenylephrine,
and the signaling induced by the D4 receptor agonist was blocked
by the adrenergic receptor antagonist REC 15/2615 and CGP
20712 (Figure 4E and F). These results matched the cross-
antagonism observed in transfected cells, thus strongly indicating
that D4 receptors form functional heteromers with a1B and b1
receptors in the pineal gland.
Direct Detection of a1B-D4 and b1-D4 Receptor
Heteromers in the Pineal Gland
Biophysical techniques to detect heteromers directly cannot be
easily applied in native tissue, but other direct methods can be
used. One example is the application of the newly developed
proximity ligation assay (PLA). This technique has been success-
fully employed to detect protein dimers in cells and in tissue [42].
Prior to performing PLA, we first confirmed the antibody
specificity. The antibody against D4, a1B,o rb1 receptor only
stained cells expressing the corresponding receptor but not non-
transfected cells, and cells expressing D4 receptors were not stained
by antibodies against adrenergic receptors, and cells expressing
a1B or b1 receptors are not stained with anti-D4 receptors antibody
(Figure S7). The selectivity for anti-D4 antibody was also
demonstrated by taking advantage of the fact that rat pineal
Drd4 mRNA expression was found to be circadian in nature, being
high at the last part of the dark period and very low during the
light period [8,9]. Thus, without the need of genetically
manipulated animals, we observed that the anti-D4 antibody was
able to stain pinealocytes from pineal glands extracted just after
the darkness period but not pinealocytes from glands extracted at
the end of the light period (Figure 5A). The expression of both
adrenergic receptors was similar in both periods (Figure 5B and
C). After testing the expression of the individual receptors using
immunofluorescence in pinealocytes, we next looked for evidence
Pineal Gland a1B-D4 and b1-D4 Receptor Heteromers
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gland using the proximity ligation assay. This direct method
requires that both receptors be close enough to allow the two
different antibody probes to be able to ligate (,17 nm) [42,43]. If
the receptors are within sufficient proximity, a punctate fluorescent
signal can be detected by confocal microscopy (see Materials and
Methods). We found that the endogenously expressed D4 receptors
do indeed form heteromers with the endogenous expressed a1B
and b1 receptors in a primary culture of pinealocytes obtained
from a pineal gland dissected 1 h after the start of the light period
(Figure 5D and E, punctate pattern of fluorescence in the upper
images), but we did not observe receptor interaction, in the form of
a fluorescent signal, for negative controls tested in the absence of
primary antibodies (Figure S8) or for a1B-b1 receptors (Figure 5F).
These results were consistent with the BRET experiments and
demonstrated a1B-D4 and b1-D4 receptor heteromers expression
in pinealocytes. As we observed a severe depletion of D4 receptor
expression in pinealocytes from glands isolated at the end of the
light period, we performed the PLA experiments also with glands
isolated at the end of the light period. As expected, no a1B-D4
and b1-D4 receptor heteromers were detected (Figure 5D and E,
lower images). These results not only confirm the specificity of the
results in Figure 5D and E (top images), but also demonstrate the
circadian nature of heteromer formation. To confirm the
circadian nature of heteromer formation we performed co-
immunoprecipitation experiments using glands dissected 1 h after
the start of the light period (sunrise) or glands isolated at the end
of the light period (sunset). Although adrenergic receptors are
Figure 3. Functional characteristics of a1B-D4 and b1-D4 receptor heteromers in transfected cells. CHO cells were transfected with 2 mgo f
plasmid coding for D4 receptors or with 3 mg of plasmid coding for a1B receptors or b1 receptors alone (A) or in combination (B to G). In (A), the
selectivity of ligands was tested by measuring ERK 1/2 (Thr
183-Tyr
185) and Akt (Ser
473) phosphorylation in cells expressing D4, a1B,o rb1 receptors,
treated for 7 min with 1 mM RO 10-5824, phenylephrine, or isoproterenol. In (B to E), cells expressing D4 and a1B receptors (B and C) or D4 and b1
receptors (D and E) were treated for 7 min with increasing concentrations of phenylephrine (B and C) or isoproterenol (D and E) in the presence (#)
or in the absence (N) of 500 nM RO 10-5824. The immunoreactive bands, corresponding to ERK 1/2 (B and D) and Akt (C and E) phosphorylation of
four experiments, were quantified and expressed as mean 6 S.E.M. of arbitrary units. In (F and G) membranes of cells expressing D4 and a1B receptors
(F) or D4 and b1 receptors (G) were used to perform competition binding experiments of a1 receptor antagonist [
3H]prazosin (1 nM) versus increasing
concentrations of phenylephrine (1 nM to 1 mM) (F) or b1 receptor antagonist [
3H]CGP-12177 (1 nM) versus increasing concentrations of
isoproterenol (1 nM to 1 mM) (G) in the presence (#) or in the absence (N) of 500 nM RO 10-5824.
doi:10.1371/journal.pbio.1001347.g003
Figure 4. Cross-antagonism between D4 and a1B or b1 receptors in transfected cells and in pineal gland. In (A to D) CHO cells were
transiently co-transfected with 2 mg of plasmid coding for D4 receptors and with 3 mg of plasmid coding for a1B receptors (A and B) or b1 receptors (C
and D). In (E and F) rat pineal glands were extracted at 9:00 h and processed as indicated in Materials and Methods. Cells were treated for 7 min and
pineal glands were treated for 10 min with 500 nM of RO 10-5824 (RO), phenylephrine (Phenyl), or isoproterenol (Iso) or with 1 mM of L-745,870 (L-
745), REC 15/2615 (REC), or CGP 20712 (CGP), alone or in combination. The immunoreactive bands, corresponding to ERK 1/2 (Thr
183-Tyr
185)
phosphorylation (A, C, and E) and Akt (Ser
473) phosphorylation (B, D, and F) of four experiments were quantified and values represent the mean 6
S.E.M. of the fold increase with respect to basal levels found in untreated cells. Significant differences were calculated by a one-way ANOVA followed
by post hoc Bonferroni’s tests (***p,0.001, as compared to the basal level;
#p,0.001, as compared to the sample treated with RO 10-5824;
$p,0.001,
as compared to the sample treated with phenylephrine;
&p,0.001, as compared to the sample treated with isoproterenol). A representative Western
blot is shown at the top of each panel.
doi:10.1371/journal.pbio.1001347.g004
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precipitating with anti-D4 receptor antibodies led to co-precip-
itation of both a1B and b1 receptors only from glands extracted at
the sunrise period and not from glands extracted at the sunset
period (Figure 5H), indicating the heteromer expression in the
pineal gland and the circadian nature of the heteromerization.
The lack of heteromer formation between a1B and b1 receptors
seen earlier by BRET and immunoprecipitation in transfected
cells was confirmed in pineal gland by co-immunoprecipitation
experiments (Figure 5H).
Functional Consequences of a1B-D4 and b1-D4 Receptor
Heteromer Formation in the Pineal Gland
To test the effect of receptor co-activation in a1B-D4 and b1-D4
receptor heteromers in the p-ERK 1/2 and p-Akt/PKB produc-
tion, pineal glands, isolated at 9:00 h, 1 h after the start of the light
Figure 5. D4 receptors form heteromers with a1B and b1 receptors in the pineal gland. In (A to C), pinealocytes were isolated from pineal
glands extracted at 9:00 h (top) or at 20:00 h (bottom) and stained using anti-S-arrestin antibody (green) and anti-D4 (A), anti-a1B (B), or anti-b1 (C)
antibodies (red) as indicated in Materials and Methods. Scale bar, 5 mm. In (D to F), pinealocytes were isolated from pineal glands extracted at 9:00 h
(top) or at 20:00 h (bottom) and the expression of a1B-D4 (D) and b1-D4 (E) receptor heteromers was visualized as punctate red fluorescent spots
detected by confocal microscopy using the proximity ligation assay (see Materials and Methods). Any expression of a1B-b1 receptor heteromers was
seen (F). Scale bar, 20 mm. In (G and H), co-immunoprecipitation of D4 and a1B or D4 and b1 receptors from pineal gland extracted at 9:00 h (sunrise)
or at 20:00 h (sunset) was performed. Glands were solubilized and processed for immunoprecipitation as described under Materials and Methods
using goat anti-D4, rabbit anti-a1, or goat anti-b1 receptor antibodies or goat anti-adenosine A2B receptor antibody as a negative control (N.C.).
Solubilized gland membranes (G) and immunoprecipitates (H) were analyzed by SDS-PAGE and immunoblotted using rabbit anti-a1, rabbit anti-b1
receptor antibodies, or goat anti-b1 receptor antibody. Immunoprecipitation experiments with anti-a1 or anti-b1 receptor antibodies (right image in
H) were performed with pineal glands extracted at 9:00 h. IP, immunoprecipitation; WB, western blotting; MW, molecular mass.
doi:10.1371/journal.pbio.1001347.g005
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rine, or isoproterenol alone or in combination. Co-activation with
RO 10-5824 and phenylephrine or with RO 10-5824 and
isoproterenol induced a significant decrease of p-ERK 1/2
production compared with stimulation with one agonist alone
(Figure 6A). Co-activation completely blocked the formation of p-
Akt/PKB in cells stimulated with RO 10-5824, phenylephrine, or
isoproterenol (Figure 6B). These results indicate that there is a
negative cross-talk between D4 and a1B or b1 receptors not only in
transfected cells but also in the pineal gland. To be sure that the
data reflected a true negative cross-talk between D4 and a1B or b1
receptors, and not a time displacement of the signaling, we
performed time-response experiments with pineal glands (Figure
S9). The effect of co-activation with RO 10-5824 and phenyleph-
rine or with RO 10-5824 and isoproterenol on a1B and b1
signaling was not due to a change in timing of the signal, with
maximal signal obtained at 10 min. In addition, at all times
examined no p-Akt/PKB signal was detected in the presence of
both adrenergic agonists and RO 10-5824. These data support the
conclusion that the results observed in Figure 6A and B were
indeed due to a true negative cross-talk.
As the expression of D4 receptor in the pineal gland is regulated
by a cycle of light/dark, we reasoned that if we isolated pineal
gland after 12 h of light (at sunset) when the levels of D4 receptor
are low, then we should now lose the negative cross-talk seen in
Figure 6A and B. To test this, we stimulated pineal gland extracted
at 20:00 h and compared signaling after stimulation with RO 10-
5824 in the presence or absence of phenylephrine and isoproter-
enol. As shown in Figure 6C and D, there was no inhibition of a1B
and b1 receptor-mediated MAPK and Akt/PKB activation by the
D4 receptor agonist RO 10-5824 in glands isolated at the end of
the light period (sunset), a time of low D4 receptors expression.
This was in contrast to signaling in glands extracted at 9:00 h, just
after the dark period (sunrise) where D4 receptors are expressed
and negative cross-talk in agonist-induced signaling was observed
(Figure 6A and B).
Figure 6. Functional characteristics of a1B-D4 and b1-D4 receptor heteromers in pineal gland. Pineal glands extracted at 9:00 h (A and B)
or at 20:00 h (C and D) were treated for 10 min with RO 10-5824 (RO), phenylephrine (Phenyl), or isoproterenol (Iso) at 1 mM concentration alone or in
combination. The immunoreactive bands, corresponding to ERK 1/2 (Thr
183-Tyr
185) (A and C) or Akt (Ser
473) (B and D) phosphorylation, of three
experiments performed in duplicates were quantified, and values represent the mean 6 S.E.M. of the fold increase with respect to basal levels found
in untreated pineal glands. Significant differences were calculated by a one-way ANOVA followed by post hoc Bonferroni’s tests (**p,0.01 and
***p,0.001, as compared to the basal level.
#p,0.05 and
##p,0.01, as compared to the sample treated with phenylephrine;
$p,0.05 and
$$$p,0.001, as compared to the sample treated with isoproterenol). A representative Western blot is shown at the bottom of each panel.
doi:10.1371/journal.pbio.1001347.g006
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Receptor Heteromers Activation in the Pineal Gland
Finally, we sought to understand how a1B-D4 and b1-D4
receptor heteromers might modulate pineal gland function. A
major role of the pineal gland is controlling the levels of melatonin
and its precursor 5-HT via synthesis and release. The a1B receptor
controls 5-HT and melatonin release via potentiation of the
calcium-induced exocytosis, while the b1 receptors can modify the
synthesis of both 5-HT and melatonin [15–18]. With this in mind,
we tested the role of the a1B-D4 and b1-D4 receptor heteromers in
5-HT and melatonin synthesis and release. Ideally, to test the
physiological importance of heteromers, one would like to create a
targeted knockout animal lacking one of the partner receptors in
the tissue of interest to be compared with wild type animals.
However, in the case of D4 receptor expression in the pineal gland,
nature provided a suitable alternative. We decided to take
advantage of the fact that D4 receptor expression is altered by
the cycle of light and dark and compare results obtained with
pineal gland extracted at the end of the light period (sunset), when
D4 receptors are not expressed, with those obtained with glands
extracted at the end of the dark period (sunrise), when D4
receptors are expressed.
We treated pineal glands, isolated at 20:00 h, when a1B-D4 and
b1-D4 receptor heteromers are not expressed, with specific agonists
and/or antagonists and measured the amount of 5-HT synthesized
(Figure 7A and C) or released (Figure 7B and D) and the amount
of melatonin synthesized (Figure 7E and G) or released (Figure 7F
and H). As can be seen in Figure 7A to H, treatment with the D4-
specific agonist, RO 10-5824 showed no increase in either 5-HT
or melatonin synthesis or release compared to basal levels. In
contrast, we observed a large increase in melatonin synthesis and
release when the glands were treated with the b1 receptor agonist
isoproterenol or the a1B agonist phenylephrine, respectively
(Figure 7E to H), and a significant increase in 5-HT synthesis
and release when the glands were treated with isoproterenol or
phenylephrine (Figure 7A to D). The increases in 5-HT and
melatonin synthesis and release could be blocked only by the
corresponding specific antagonists of adrenergic receptors but not
by the D4 receptor antagonist L-745,870 (Figure 7A, B, E, and F),
demonstrating a lack of cross-antagonism due to the absence of the
heteromers. In addition, when we treated the glands with either
phenylephrine or isoproterenol in the presence of the dopamine
D4 receptor agonist RO 10-5824 (Figure 7C, D, G, and H), no
negative cross-talk between dopamine D4 and adrenergic recep-
tors could be detected. The role of adrenergic receptors is
represented in Figure 7I. In contrast and very interestingly, when
pineal glands were isolated at 9:00 h, at sunrise (when D4 receptor
expression increases and a1B-D4 and b1-D4 receptor heteromers
are expressed) and were stimulated as before with agonists of both
a1B and b1 receptors in the presence of either the pertinent
antagonist or the D4 antagonist, we observed that 5-HT and
melatonin synthesis and release could be blocked not only by the
corresponding specific antagonists of adrenergic receptors but also
by the D4 receptor antagonist L-745,870 (Figure 7J, K, N, and O).
This demonstrates a clear cross-antagonism. In addition, when we
treated the glands with either phenylephrine or isoproterenol in
the presence of the dopamine D4 receptor agonist RO 10-5824, a
complete block in the ability of either ligand to increase 5-HT or
melatonin synthesis or release was observed (Figure 7L, M, P, and
Q). This shows that, in these conditions, a negative cross-talk
between dopamine D4 and adrenergic receptors exists in the
pineal gland. A schematic representing the influence of dopamine
on 5-HT and melatonin synthesis and release in these conditions is
represented in Figure 7R. These data provide strong evidence that
the role of the dopamine D4 receptor via either a1B-D4 and b1-D4
receptor heteromers is to modify the melatonin metabolic pathway
in the pineal gland.
Discussion
In the present study we identified a previously unknown
mechanism for how dopamine can regulate adrenergic receptor
function in a circadian fashion. By applying a number of different
experimental approaches, we were able to identify (1) that
functional dopamine D4 receptors form heteromers with both
a1B- and b1 adrenergic receptors in transfected cells and in the
pineal gland; (2) that the a1B-D4 and b1-D4 receptor heteromers
allow direct modulation of the adrenergic agonist-induced MAPK
and Akt signaling by the D4 receptor agonist and antagonist in
transfected cells and in the pineal gland; (3) that the synthesis of
melatonin and its precursor 5-HT, promoted by adrenergic
receptor stimulation in the pineal gland, can be controlled by D4
receptor activation via a1B-D4 and b1-D4 receptor heteromers;
and (4) that this D4 receptor heteromer-mediated modulation is
dependent on the circadian light/dark cycle. This is the first
example, to our knowledge, of a circadian-dependent modulation
of receptor heteromerization. Together these findings point to a
new role for the D4 receptor in the pineal gland where D4 receptor
activation modifies a1B- and b1 adrenergic receptor function by a
direct receptor-receptor interaction, which can limit the levels of
melatonin secreted by the pineal gland.
The adrenergic receptors are the mainstay receptors of pineal
gland function. They form the bridge between the circadian
controlled release of norepinephrine by the surrounding sympa-
thetic nerve terminals and the melatonin production of the pineal
gland. The adrenergic receptors are thought to control the
production of melatonin through a variety of mechanisms,
including control of the levels of the melatonin precursor 5-HT
[15,16]. Dopamine is also present in the afferent sympathetic
nerves in the pineal gland, not only as a precursor of
norepinephrine, but is also proposed to be co-released to a lesser
extent with norepinephrine [8].
The ‘‘receptor heteromer’’ concept, in which receptors of the
same and different gene families can combine among themselves
to generate new and unique biochemical and functional charac-
teristics, is becoming widely accepted for GPCRs and constitutes
an emerging area in the field of GPCR signaling and function
regulation [30]. To date there had been no demonstration of
heteromers involving dopamine and the adrenergic receptors.
Here, by means of BRET experiments in transfected cells and by
proximity ligation assays in pinealocytes, we present direct
evidence that the D4 receptor forms heteromers with both the
a1B and b1 adrenergic receptors. The formation of a1B-D4 and b1-
D4 receptor heteromers in the pineal gland manifests itself in the
form of cross-antagonism. We observed that a D4 receptor-specific
antagonist was able to block the signaling through both a1B- and
b1 adrenergic receptors. The specific antagonists of a1B- and b1
adrenergic receptors were also able to block signaling through D4
receptors. This is a clear example of cross-antagonism in a
receptor heteromer [44–46], since by definition an antagonist is
not able to induce intracellular signaling. This statement is a propos
in our case since none of the antagonists used here demonstrated
any signaling activity. Thus the simplest way to explain the effect
of a D4 receptor antagonist on a1B and b1 receptor activation and
vice versa is through a direct protein-protein interaction between
both receptors.
The functional consequences of this protein-protein interaction
is a negative cross-talk between both receptors in the a1B-D4 and
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PLoS Biology | www.plosbiology.org 10 June 2012 | Volume 10 | Issue 6 | e1001347Figure 7. Metabolic consequences of a1B-D4 and b1-D4 receptor heteromers activation. 5-HT synthesis (A, C, J, L) and release (B, D, K, M)
and melatonin synthesis (E, G, N, P) and release (F, H, O, Q) were measured as described in Materials and Methods in pineal gland extracted at 20:00 h
(A to H) or at 9:00 h (J to Q). Pineal glands were not treated (basal) or treated with 500 nM RO 10-5824 (RO), 500 nM phenylephrine (Phe), 500 nM
isoproterenol (Iso), 1 mM L-745,870 (L-745), 1 mM REC 15/2615 (REC), or 1 mM CGP 20712 (CGP), alone or in combination. Three experiments were
quantified and values represent the mean 6 S.E.M. of the fold increase with respect to basal levels found in untreated pineal glands. Significant
differences were calculated by a one-way ANOVA followed by post hoc Bonferroni’s tests (*p,0.01 as compared to the basal level;
#p,0.005 as
compared to the sample treated with isoproterenol or with phenylephrine). In (I and R) the overall results are presented as a scheme.
doi:10.1371/journal.pbio.1001347.g007
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ERK 1/2 induced by adrenergic agonists in the presence of D4
receptor agonist and the complete block of p-Akt production when
both receptors in the heteromer were co-stimulated. In the pineal
gland, D4 receptor mRNA expression is tightly regulated so that it
is highest during the last part of the dark period [8]. Accordingly,
we show that the D4 receptor is expressed and is functional in
pineal glands isolated at sunrise and we saw no activity and no
expression when pineal glands were isolated at sunset, the end of
the light period. Our finding that the D4 receptor can modify the
downstream signaling of the a1B and b1 adrenergic receptors is
particularly interesting as D4 receptor expression was found to be
modified by an increase in norepinephrine levels [8]. Norepi-
nephrine levels are also known to increase at night, and it is
through its binding to the adrenergic receptors that the level of D4
receptor mRNA is thought to reach the maximum at the end of
the dark period [8]. Thus, the mechanism we describe may
represent a feedback inhibition, where increased expression of D4
receptor via adrenergic signaling leads to an increase of a1B-D4
and b1-D4 receptor heteromers, which then inhibit adrenergic-
induced signaling through the above described cross-talk. The
detailed molecular mechanism for how this feedback occurs is less
clear. It is known that heteromers can function in a variety of
different mechanisms, including allosterically, asymmetrically,
and/or through cooperativity [23,29,47]. The binding experi-
ments in transfected cells suggest, at least for the a1B-D4 receptor
heteromer, there is inhibition at the level of ligand binding. Why is
this not seen for b1-D4 receptor heteromer? Does this reflect
differences in heteromer plasticity—for example, protomer-proto-
mer molecular interactions promoted by ligand binding to one
protomer inducing structural changes in the other protomer that
are sensed at both ligand binding and signaling levels in one case
and only at the signaling level in the other case? Or are these
results due to something experimentally related—for example, the
differences of ligands used? More experiments will be required to
identify how exactly these particular heteromers function. An
interesting corollary to heteromer function and the data presented
here is that a recent proposal arguing against the existence of
heteromers and heteromer function suggested that GPCRs were
competing for available G-proteins and that any cross-signaling
effects observed were due to this competition [48]. Our results
argue against this possibility, at least in the case of a1B-D4 and b1-
D4 receptor heteromers, as none of these receptors use the same
G-proteins to signal. We have observed cross-talk at the level of p-
ERK 1/2 and p-Akt, two steps along the production and release of
melatonin. Separately all three receptors studied can activate both
signaling pathways; thus, heteromer formation by a protein-
protein interaction clearly alters the ability of these receptors to
signal using these pathways. Cross-talk has been observed for other
heteromers [24,25,38,49], and the mechanisms have varied from
changes in b-arrestin recruitment, changes in receptor trafficking,
changes in G-protein coupling, and/or changes in ligand binding.
More experiments will be required to understand the molecular
mechanism at play in the pineal gland. Another possible
interpretation of our signaling results is that some downstream
effect after D4 receptor activation might cause adrenergic receptor
signaling to be inhibited. This does not seem to be the mechanism
of action for the a1B-D4 heteromers based on the fact that the
inhibition occurs at the binding level as well. However, although
we cannot completely rule out this possibility for b1-D4, the fact
that there is cross-antagonism and that the receptors are in a
complex suggests an indirect mechanism of inhibition is less likely.
We have also studied the metabolic consequences of a1B-D4 and
b1-D4 receptor heteromer activation at the level of melatonin
synthesis and release, as well as the precursor of melatonin, 5-HT.
Melatonin levels are increased at night while 5-HT levels fluctuate
in the opposite manner, with production and secretion increasing
during the day. Through mass action, large changes in AANAT
activity at night, the enzyme in the last step to melatonin synthesis,
can rapidly decrease the levels of 5-HT, yielding large increases in
melatonin [50]. It is important to point out that 5-HT synthesis is
thought to occur both during the day and at night, and nocturnal
synthesis and release of 5-HT is required for maximal adrenergic
stimulation of melatonin synthesis [51,52]. Extracellular 5-HT is
either taken up by surrounding sympathetic nerves or binds
5HT2C receptors on the pineal gland, which in turn can lead to
increased melatonin synthesis and release [51,53]. To date it has
not been entirely clear what limits the maximum nighttime and
minimum daytime rates of melatonin production. Our data
suggest that a1B-D4 and b1-D4 receptor heteromers may play an
important role in this process. In pineal glands, isolated at the end
of the light period (sunset) when the expression of D4 receptor is
negligible, treated with adrenergic ligands, we have seen a large
increase in melatonin and a moderate increase in 5-HT synthesis
mediated by b1 receptors and release mediated by a1B receptors
(Figure 7I). In this case neither synthesis nor release of 5-HT or
melatonin was blocked by treating the gland simultaneously with a
D4 receptor agonist or was modified in the presence of D4 receptor
antagonist. In these conditions the pineal gland is starting the
melatonin production during the dark period. In pineal glands,
isolated at the end of the dark period (sunrise) when the D4
receptor is expressed, treated with adrenergic ligands, we have also
seen a large increase in melatonin and 5-HT synthesis mediated by
b1 receptors and release mediated by a1B receptors. Interestingly,
both synthesis and release were blocked by treating the gland
simultaneously with a D4 receptor agonist (Figure 7). Thus,
dopamine appears to be able to regulate the melatonin and 5-HT
levels as seen in Figure 7R. This suggests that dopamine, via a1B-
D4 and b1-D4 receptor heteromers, may serve both as a buffer to
control the amount of 5-HT that can be made and released during
the light period, limiting total melatonin production, and be
partially responsible for the block of melatonin production after
the dark period. During the day, D4 receptors would begin to be
down-regulated, less a1B-D4 and b1-D4 receptor heteromers would
be formed, AANAT would be also down-regulated, maintaining a
reduced melatonin production, 5-HT levels would gradually
increase, and the cycle could repeat. These findings provide the
first report of a role for the D4 receptor in the pineal gland and
suggest a new area of research on how dopamine receptors, by
means of a circadian-related heteromerization with adrenergic
receptors, may help maintain the circadian rhythm signals
emulating from the pineal gland.
Materials and Methods
Fusion Proteins and Expression Vectors
The cDNA for human dopamine D4 and adrenergic a1B and b1
receptor genes expressed in the pcDNA3.1 vector were amplified
without its stop codon using sense and antisense primers to be
cloned in the mammalian humanized pRluc-N1 or in the EYFP-
N3 vectors (see Text S1).
Cell Culture and Transient Transfection
CHO or HEK-293T cells were grown in supplemented a-MEM
or Dulbecco’s modified Eagle’s medium (DMEM) medium,
respectively, and they were transfected by the polyethylenimine
(PEI) method (see Text S1).
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HEK-293T cells were grown on glass coverslips and transiently
transfected. After 48 h of transfection, cells were fixed and labeled
with the corresponding antibodies (see Text S1).
BRET Assay
HEK-293T cells were co-transfected with a constant amount of
cDNA encoding for the receptor fused to Rluc and with increasing
amounts of cDNA encoding to the receptor fused to YFP to
measure BRET. BRET was expressed as milli BRET Units (mBU)
and is the BRET ratio61,000 (see Text S1).
Pineal Gland Dissection and Culture
Male Sprague Dawley rats (3-mo-old, <350 g), receiving water
and food ad libitum, were obtained from the animal facility of the
Faculty of Biology (University of Barcelona). Rats were housed in
light:dark 12:12 lighting cycles starting light at 8:00 h and dark at
20:00 h, and 4% Isoflurane (2-chloro-2-(difluoromethoxy)-1,1,1-
trifluoro-ethane) anesthetized animals were killed by decapitation
at 9:00 h (just after the dark period) or at 20:00 h (after light
period) and pineal glands were immediately dissected. All
procedures were approved by the Catalan Ethical Committee
for Animal Use (CEAA/DMAH 4049 and 5664). Rat pineal
glands were cultured in defined culture medium (BGJb, Invitro-
gen, Carlsbad, CA) containing 10% (v/v) fetal bovine serum (heat-
inactivated) for 24–36 h and cultured in serum-free medium for
16 h before the addition of agonists and/or antagonists for
signaling experiments or were overnight cultured in HBSS
medium (137 mM NaCl, 5 mM KCl, 0.34 mM Na2H-
PO4.12H2O, 0.44 mM KH2PO4, 1.26 mM CaCl2.2H2O,
0.4 mM MgSO4.7H2O, 0.5 mM MgCl2, 10 mM HEPES,
pH 7.4), supplemented with 0.1% glucose, 100 U/ml penicillin/
streptomycin, and 1 mg/ml bovine serum albumin, containing
agonist and/or antagonist for serotonin synthesis and release
determination.
Coimmunoprecipitation
Transfected cells or pineal glands were solubilized by homog-
enization in ice-cold immunoprecipitation buffer and were
processed for immunoprecipitation as described in the immuno-
precipitation protocol using a Dynabeads Protein G kit (Invitro-
gen) (see Text S1).
Detection of MAPK and Akt/PKB Phosphorylation
Transfected cells or pineal glands were cultured in serum-free
medium before the addition of the indicated concentration of
ligands for the indicated time. Both cells and pineal glands were
washed and lysed. Proteins were separated by electrophoresis and
ERK 1/2 (Thr
183-Tyr
185) and Akt (Ser
473) phosphorylation was
determined by Western blot and band densities were quantified
(see Text S1).
Radioligand Binding Experiments
Competition experiments were performed using membranes
from cells expressing D4 and a1B or b1 receptors. Membranes were
incubated with the indicated concentration of the a1B receptor
antagonist [
3H]prazosin or b1 receptor antagonist [
3H]CGP-
12177 (PerkinElmer Life and Analytical Sciences) and increasing
concentrations of phenylephrine or isoproterenol, respectively, in
the absence or in the presence of the indicated concentration of
the D4 receptor agonist RO 10-5824 (Tocris, Aronmouth, UK)
(see Text S1).
Pinealocyte Culture, Signaling, and
Immunocytochemistry
Pinealocytes were prepared from rat pineal glands as previously
described by Silveira Cruz-Machado et al. [54] and maintained in
culture no more than 48 h. For signaling experiments, pinealo-
cytes were treated with specific agonist, fixed with paraformalde-
hyde, and treated with the corresponding antibodies (see Text S1).
In Situ Proximity Ligation Assay (PLA)
The primary cultures of pinealocytes were fixed and permea-
bilized as described above. The receptor-receptor molecular
interaction was detected using the Duolink II in situ PLA
Detection Kit (see Text S1).
Serotonin Synthesis and Release Determination
After 36 h of culture in BGJb medium, pineal glands were
incubated in supplemented HBSS medium for 12 h with specific
agonist and/or antagonist and radioactive [
14C]-Tryptophan
(10 mM). Medium and pineal glands were collected separately
and [
14C]-serotonin in medium or in homogenized glands was
separated by HPLC chromatography coupled to detection by
fluorescence and counted in a liquid scintillation counter (see Text
S1).
Melatonin Synthesis and Release Determination
After 36 h of culture in BGJb medium, the pineal glands were
incubated for 12 h with specific agonist and/or antagonist in
supplemented HBSS medium. After incubation, media were
collected into eppendorf tubes and pineal glands were homoge-
nized by sonication in a Dynatech/Sonic Dismembrator (Dyna-
tech Labs, Chantilly, VA) for 15 s. An aliquot was reserved for
protein quantification by the Lowry method, and cellular debris
was removed by centrifugation at 10,000 g for 10 min at 4uC.
Melatonin was quantified using a radioimmunoassay kit with
[
125I]-melatonin (DiaSource, Belgium) following the instructions of
the supplier.
Supporting Information
Figure S1 Functionality of the fusion proteins. HEK 293T cells
were transfected with 2 mg of plasmid coding for the D4 receptor
or with 3 mg of plasmid coding for the adrenergic a1B or b1
receptors or to the corresponding fusion proteins D4-RLuc, a1B-
YFP, a1B-RLuc, or b1-YFP. 48 h post-transfection, cells expressing
D4 or D4-RLuc receptors were treated with 500 nM RO 10-5824,
cells expressing a1B, a1B-YFP or a1B-RLuc receptors were treated
with 1 mM phenylephrine, or cells expressing b1 or b1-YFP were
treated with 1 mM isoproterenol for 7 min and ERK 1/2 (Thr
183-
Tyr
185) phosphorylation was determined. The immunoreactive
bands of three experiments performed in duplicates were
quantified and expressed as mean 6 S.E.M. of arbitrary units.
A representative Western blot is shown at the top. Significant
differences with respect to basal levels were calculated by one-way
ANOVA followed by a Dunnett’s multiple comparison post hoc
test (**p,0.01 and ***p,0.001).
(TIF)
Figure S2 Specificity of the antibodies used for co-immunopre-
cipitation experiments. Membranes from cells expressing the
indicated receptors were solubilized and processed for immuno-
precipitation as described under Materials and Methods using goat
anti-D4 or rabbit anti-a1 receptor antibodies or goat anti-
adenosine A2B or rabbit anti-adenosine A1 receptor antibodies as
negative controls. Solubilized membranes (Load) and immuno-
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using rabbit anti-YFP, rabbit anti-a1, rabbit anti-b1, or goat anti-
b1 receptor antibodies. IP, immunoprecipitation; WB, Western
blotting; MW, molecular mass.
(TIF)
Figure S3 ERK 1/2 and Akt phosphorylation in cells transfect-
ed with D4, a1B,o rb1 receptors. CHO cells were transfected with
2 mg of plasmid coding for the D4 receptor (A, D), 3 mg of plasmid
coding for the a1B receptor (B, E), or 3 mg of plasmid coding for
the b1 receptor (C, F). 48 h post-transfection, cells were treated for
increasing time with 500 nM RO 10-5824 (A, D), 1 mM
phenylephrine (B, E), or 1 mM isoproterenol (C, F). The
immunoreactive bands, corresponding to ERK 1/2 (Thr
183-
Tyr
185) (A to C) and Akt (Ser
473) (D to F) phosphorylation, of
three experiments were quantified and expressed as mean 6
S.E.M of arbitrary units. Statistical differences over non-treated
cells were determined by one-way ANOVA followed by a
Dunnett’s multiple comparison post hoc test (*p,0.05,
**p,0.01, and ***p,0.001).
(TIF)
Figure S4 Time-response on ERK 1/2 and Akt phosphorylation
by co-activation of a1B-D4 and b1-D4 receptor heteromers in cell
cultures. CHO cells were transfected with 2 mg of plasmid coding
for the D4 receptor and 3 mg of plasmid coding for the a1B
receptor (A) or the b1 receptor (B). 48 h post-transfection, cells
were treated with 1 mM phenylephrine (Phenyl, A) or 1 mM
isoproterenol (Iso, B) alone or in the presence of 1 mM RO 10-
5824 for different times. A representative Western blot is shown.
(TIF)
Figure S5 Selectivity of D4, a1B,o rb1 receptor agonists. The
selectivity of ligands was tested by measuring ERK 1/2 (Thr
183-
Tyr
185) (A) and Akt (Ser
473) (B) phosphorylation in cells expressing
D4, a1B,o rb1 receptors, treated for 7 min with 1 mM RO 10-5824
(RO), phenylephrine (Phe), or isoproterenol (Iso) alone or in
combination as indicated.
(TIF)
Figure S6 Selectivity of D4, a1B,o rb1 receptor antagonists.
CHO cells were transfected with 2 mg of plasmid coding for the D4
receptor or with 3 mg of plasmid coding for a1B or b1 receptors.
48 h post-transfection, cells were treated for 7 min with 500 nM
RO 10-5824 (RO), 500 nM phenylephrine (Phenyl), 500 nM
isoproterenol (Iso), 1 mM L-745,870 (L-745), 1 mM REC 15/2615
(REC), or 1 mM CGP 20712 (CGP) alone or in combination. The
immunoreactive bands, corresponding to ERK 1/2 (Thr
183-
Tyr
185) (A) and Akt (Ser
473) (B) phosphorylation, of three
experiments were quantified and values represent the mean 6
S.E.M. of the fold increase over basal levels found in untreated
cells (basal). Significant differences over basal levels were
determined by one-way ANOVA followed by a Dunnett’s multiple
comparison post hoc test (*p,0.05, ***p,0.001). A representative
Western blot is shown at the top.
(TIF)
Figure S7 Specificity of the antibodies tested by immunocyto-
chemistry. In (A) non-transfected HEK-293T cells (right panels)
and cells transfected with, top to bottom, 1 mg of plasmid coding
for D4 receptor, 0.5 mg cDNA coding for a1B receptor, or 0.5 mg
cDNA coding for b1 receptor (left panels) were stained using, top
to bottom, anti-D4, anti-a1, or anti-b1 antibodies as indicated in
Materials and Methods. Scale bar, 5 mm. In (B to J), cells were
transfected with 1 mg of plasmid coding for D4-YFP receptor (B to
D), 0,5 mg cDNA coding for a1B-YFP receptor (E to G), or 0.5 mg
cDNA coding for b1-YFP receptor (H to J). The expression of the
receptors was detected by its own YFP fluorescence (B, E, and H)
or by using anti-a1 (C and J), anti-b1 (D and G), or anti-D4 (F and
I) receptor antibodies. Scale bar, 5 mm.
(TIF)
Figure S8 Negative controls for in situ proximity ligation assays.
Negative controls for in situ proximity ligation assays (PLA, see
Materials and Methods) are shown demonstrating a lack of
punctate red fluorescence staining in pinealocytes in the absence of
primary antibodies, left to right, anti-D4, anti-a1, or anti-b1
antibodies. Scale bar, 20 mm.
(TIF)
Figure S9 Time-response on ERK 1/2 and Akt phosphorylation
by co-activation of a1B-D4 and b1-D4 receptor heteromers in
pineal gland. Pineal glands extracted at 9:00 h were treated with
1 mM phenylephrine (Phenyl) or 1 mM isoproterenol (Iso) in the
presence of 1 mM RO 10-5824 for the times indicated. A
representative Western blot is shown.
(TIF)
Text S1 Additional details on materials and methods used
throughout the article.
(DOC)
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